Trial in progress: A phase II switch maintenance study of live biotherapeutic MRx0518 and avelumab in patients with unresectable locally advanced or metastatic urothelial carcinoma (UC) who did not progress on first-line platinum-containing chemotherapy.

Bavencio (avelumab) - EMD Serono, Pfizer

MRx0518 - 4D Pharma

Amishi Yogesh Shah; Jianjun Gao; Arash Rezazadeh; Suzanne Cole; Rohit K. Jain; Alex Stevenson; Gayle Fyvie; Nina Jane Gaw; Shubham Pant

Apr 28, 2022